Shelton Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Shelton Capital Management's RGEN Position: Q1 2026 in Review
Shelton Capital Management reduced its Repligen (RGEN) stake by 6.7% in Q1 2026, selling an estimated $17.6K and leaving 1,744 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #671.
Shelton Capital Management first reported a position in RGEN in Q3 2018 and has held it in 31 quarters since. The position peaked at $789K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Shelton Capital Management held 1,744 shares of Repligen worth $205K as of Q1 2026.
- Shelton Capital Management sold 126 Repligen shares in Q1 2026, an estimated $17.6K.
- Repligen made up ﹤0.01% of Shelton Capital Management's portfolio in Q1 2026, its #671 holding.
- Shelton Capital Management first reported a position in Repligen in Q3 2018 and has held it in 31 quarters since.
- Shelton Capital Management's Repligen position peaked at $789K in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.